JAK inhibitors and monoclonal antibodies for the treatment of atopic dermatitis : effectiveness and value : final evidence report Atlas, Steven J., author. Fox, Grace E., author. Agboola, Foluso, author. Campbell, Jonathan D., author. Pearson, Steven D., author. Rind, David M., author. Brouwer, Elizabeth, author. Carlson, Josh, author. Chen, Yilin (Of University of Washington), author. Hansen, Ryan N., author. Antibodies, Monoclonal -- therapeutic use Dermatitis, Atopic Janus Kinase Inhibitors -- therapeutic use We compared the cost and effectiveness of abrocitinib, baricitinib, tralokinumab and upadacitinib for moderate to severe atopic dermatitis to topical emollients (standard of care) and dupilumab, over a five-year time horizon taking a health system perspective. [Boston, Massachusetts] : Institute for Clinical and Economic Review, February 27, 2023 Institute for Clinical and Economic Review, issuing body. New England Comparative Effectiveness Public Advisory Council, issuing body. Technical Report Text Illustrations 1 online resource (1 PDF file (338 pages)) nlm:nlmuid-9918697384806676-pdf 9918697384806676 http://resource.nlm.nih.gov/9918697384806676 English United States Reproduced with permission of the copyright holder. Further use of the material is subject to CC BY license. http://creativecommons.org/licenses/by/4.0